<DOC>
	<DOCNO>NCT02448927</DOCNO>
	<brief_summary>This randomized trial evaluate role balloon aortic valvuloplasty ( BAV ) outcome patient undergoing transcatheter aortic valve implantation ( TAVI ) procedure . Patients undergo physical exam , coronary angiography compute tomography angiography TAVI . The randomization direct non-direct TAVI ( BAV without BAV ) take place 24 hour prior procedure core lab Hippokration Hospital Athens . The lab analyze blind fashion result image modality patient . The patient follow hospital stay 30 day 1 year thereafter echocardiography . The procedure predilatation operator 's discretion .</brief_summary>
	<brief_title>The preDIlatation tRanscathEter aortiC Valve implanTation Trial</brief_title>
	<detailed_description>Background : Balloon aortic valvuloplasty ( BAV ) vital part transcatheter aortic valve implantation ( TAVI ) procedure . There lack long-term evidence patient undergo direct TAVI without predilatation . Trial : This prospective multi-center randomize trial . Participating medical center : 1 . 1st Department Cardiology , Hippokration Hospital/Athens Medical School , Athens , Greece 2 . Heart Institute , Hadassah Hebrew University Medical Center , POB 12000 , Jerusalem 91120 , Israel . 3 . Department Cardiology , Division Internal Medicine , University Medical Centre Ljubljana , Zaloška 7 , SI-1525 Ljubljana , Slovenia . 4 . Department Cardiology , Onassis Cardiac Surgery Center , Athens , Greece 5 . Second Department Cardiology , University Hospital Ioannina , Ioannina , Greece Description : Patients undergo physical exam , coronary angiography compute tomography angiography TAVI . The randomization direct non-direct TAVI take place 24 hour prior procedure core lab Hippokration Hospital Athens . The lab analyze blind fashion result image modality patient . The patient follow hospital stay 30 day 1 year thereafter echocardiography . The procedure predilatation operator 's discretion . Access sit TAVI : transfemoral , subclavian transaortic .</detailed_description>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>1 . Diameter &gt; 5mm Evolut R &gt; 6mm CoreValve vessel . 2 . Aortic valve diameter ≥20mm ≤29mm measure echo . 3 . Ascending aorta diameter ≤ 43mm sinotubular junction . 4 . Severe aortic stenosis , define aortic valve area &lt; 1.0 cm2 ( aortic valve area index &lt; 0.6 cm2/m2 ) continuity equation , AND mean gradient &gt; 40 mmHg maximal aortic valve velocity &gt; 4.0 m/sec rest echocardiogram . 5 . STS score ≥ 8 OR LogEuroSCORE &gt; 20 % , OR 80 year old OR 65 year old 1 2 ( two ) follow criterion : Liver cirrhosis ( Class A B ) . Pulmonary insufficiency : VMS &lt; 1 liter . Previous heart surgery ( CABG , vascular surgery ) . Porcelain aorta . Pulmonary artery systolic pressure &gt; 60 mmHg high risk heart surgery . Relapsing pulmonary embolism . Right ventricular insufficiency . Thoracic wall injury contraindicate open heart surgery . History radiation therapy mediastinum . Connective tissue disease contraindicate open heart surgery . Frailty/cachexia . 6 . Patients informed nature study provide write consent . 1 . A known hypersensitivity contraindication follow adequately premedicated : aspirin heparin bivalirudin , ticlopidine clopidogrel , nitinol ( titanium nickel ) , contrast medium 2 . Ongoing sepsis , include active endocarditis . 3 . Any percutaneous coronary peripheral interventional procedure bare metal drug elute stent perform within 30 day prior Heart Team assessment . 4 . Echocardiographic evidence LV LA thrombus . 5 . Mitral tricuspid valve insufficiency ( &gt; grade II ) . 6 . Previous aortic valve replacement ( mechanical bioprosthetic ) . 7 . Recent ( within 6 month Heart Team assessment ) cerebrovascular accident ( CVA ) transient ischemic attack ( TIA ) . 8 . Patients : Femoral , iliac aortic vascular disease ( stenosis etc ) preclude insertion transcatheter sheath . OR Symptomatic carotid vertebral artery disease ( &gt; 70 % stenosis ) . 9 . The patient bleed diathesis , coagulopathy denies blood transfusion . 10 . Estimated life expectancy le 12 month due associate noncardiac comorbid condition . 11 . Creatinine clearance &lt; 20 ml/min . 12 . Active gastritis ulcer . 13 . Pregnancy . 14 . Severe leave ventricular dysfunction leave ventricular ejection fraction ( LVEF ) &lt; 20 % . 15 . Unicuspid bicuspid aortic valve . 16 . Mixed aortic valve disease ( aortic stenosis aortic regurgitation &gt; 2+ ) . 17 . Liver failure ( ChildPugh class C ) . 18 . Severe dementia ( result either inability provide inform consent study/procedure , prevents independent lifestyle outside chronic care facility , fundamentally complicate rehabilitation procedure compliance followup visit ) . 19 . Extreme aortic valve calcification calcific asymmetry ( semiquantitively measure : grade 4 , Agatston score : grade 4 AgS &gt; 5000 AU ) . 20 . Aortic valve area &lt; 0.4 cm2 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>transcatheter aortic valve implantation</keyword>
	<keyword>Balloon aortic valvuloplasty</keyword>
	<keyword>Aortic stenosis</keyword>
	<keyword>TAVI</keyword>
	<keyword>TAVR ( transcatheter aortic valve replacement )</keyword>
	<keyword>CoreValve</keyword>
	<keyword>BAV</keyword>
	<keyword>Evolut R</keyword>
</DOC>